Henney meeting with industry
This article was originally published in The Gray Sheet
Twenty-member FDA/Industry Grass Roots Initiative Task Force meets with FDA Commissioner Jane Henney Dec. 18 in Boulder, Colorado "to discuss how the agency and industry can better work together to carry out changes specified in the FDA Modernization Act," Minnesota-based trade association Medical Alley reports. The meeting includes a two-hour public session with Henney and a two-hour session with the task force, which includes representatives from HIMA, Medical Alley and other regional associations for device manufacturers
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.